Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel <i>FGFR1</i> fusion treated with pemigatinib
Carlos A. Torres‐Cabala(The University of Texas MD Anderson Cancer Center), Valentina Nardi(Biopredic (France))
Cited by 4
Related Papers
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients
|JNCI Cancer Spectrum|2019|226
Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type
|Modern Pathology|2009|211
Identification of <i>ALK</i> Rearrangements in Malignant Peritoneal Mesothelioma
|JAMA Oncology|2017|125
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
|Nature Communications|2018|114
Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment
|Clinical Cancer Research|2012|112